Does Celexa Cause Dry Skin? (5 Helpful Tips)

By Ivan Kahwa

Page last updated: 02/01/2024 | Next review date: 02/01/2026

Author bio

Mr Ivan Kahwa is a chemist and phytopharmaceutical scientist with expertise in chemistry, pharmacology, phytochemistry, and Nanobiotechnology. He writes and reviews content on these topics.

Mr Ivan Kahwa’s Highlights:

Guest Researcher at the University of Leipzig, Senior Research Fellow/Scientist, and Lecturer at the Department of Pharmacy, Faculty of Medicine, Mbarara University of Science and Technology.

Professional Experience:

Mr Ivan joined PHARMBIOTRAC as a research fellow/scientist during his master of science tenure. He contributed to the development of most of the phytopharmaceutical products in the project. Furthermore, he participated in carrying out the pharmacological activities of the developed products in laboratory animals such as mice and rats in order to develop proper doses hence leading to pre-clinical studies.

With the above relevant research experience, Ivan started to work with the University of Leipzig on collaborative projects with Mbarara University to develop the chemistry of Ugandan Medicinal plants and their pharmacological activities. This was coupled with several consultative positions by different German NGOs. Mr. Kahwa is also a supporting in the teaching and learning at the Departments of Pharmacy and Pharmaceutical Sciences, Faculty of Medicine, Mbarara University of Science and Technology.

With the increase in antimicrobial resistance globally, Ivan retooled his thinking towards developing new naturally derived antibiotic regimens from Ugandan propolis with the assistance of nanotechnology to improve their delivery to microbial cells. Kahwa has also published over 28 articles in peer-reviewed journals and he is currently reviewing for many journals.

Education:

2023-2027: PhD in Pharmaceutical Sciences (ongoing) with a focus on Pharmaceutical Microbiology and Nanobiology at Mbarara University of Science and Technology.

2022: 2Msc. in Pharmacognosy and Natural Medicine Science at Mbarara University of Science and Technology.

2018: Bachelor of Science (Chemistry) at Mbarara University of Science and Technology.

Publications:

▪ Iqbal, S., Jabeen, F., Kahwa, I., & Omara, T. 2023. Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-023-09804-7

▪ Gupta, A. K., Yadav, R., Sharma, S., Sawale, J., & Kahwa, I. 2023. Anti-ageing Activity and Antioxidant Activity of Methanol Extracts of Leaves and Flowers of Salvia officinalis and Rosmarinus officinalis. Journal of Young Pharmacists, 15(3), 448–455. https://doi.org/10.5530/jyp.2023.15.60

▪ Tolo, C.U., Kahwa, I., Nuwagira, U., Weisheit, A. and Ikiriza, H., 2023. Medicinal plants used in treatment of various diseases in the Rwenzori Region, Western Uganda. Ethnobotany Research and Applications, 25, pp.1-16.

https://ethnobotanyjournal.org/index.php/era/article/view/4683

▪ Kahwa, I., Ajayi, C.O., Yadav, R., Chauhan, N.S., Shah, K., Abdelgadir, A.A., Shegena, E.A., Daniel, S., Omara, T., Asiimwe, J.B. and Ikiriza, H., 2023. Pharmacognostic and phytochemical studies as an invaluable approach for correct identification of medicinal plants: The case of Artemisia vulgaris L. substituted for Artemisia annua L. in Western Uganda. TMR Integr Med, 7, p.e23004.

https://doi.org/10.53388/TMRIM202307004

▪ Nalimu, F., Oloro, J., Kahwa, I. and Ogwang, P.E., 2021. Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences, 7, pp.1-21.

https://doi.org/10.1186/s43094-021-00296-2

▪ Elamin, O.H.S., Ali, M.A., Elgezuli, I.A.A., Bashir, M.A. and Kahwa, I., 2021. Diagnosis of pre-and post-treatment of echinococcus granulosus with counter current immune electrophoresis and bacterial co-agglutination. Journal of Microbiology and Infectious Diseases, 11(02), pp.88-94.

https://doi.org/10.5799/jmid.951600

Published book Chapter

▪ Kahwa, I., Ayesiga, I., Nakalema, S., Alinaiswe, R., Mbabazi, R. and Iqbal, S., 2023. Natural products in the management of onchocerciasis. In Natural Products in Vector-Borne Disease Management (pp. 63-80). Academic Press. Book Chapter.

https://doi.org/10.1016/B978-0-323-91942-5.00012-4

Submitted manuscripts Under Review:

▪ Comparison of the Wound Healing Activity of the Leaf and Leaf Ash Extracts of Vernonia amygdalina in Rats. Journal name: Clinical Phytoscience

▪ Ethnobotanical Survey of Medicinal plants used in the management of cancer in Uganda. Journal name: Journal of Herbal Medicine

▪ Ethnobotanical survey and phytochemical screening of medicinal plants used in treatment of epilepsy by PROMETRA-Uganda Traditional Health Practitioners in Mpigi District, Uganda. Journal name: Journal of Ethnopharmacology

Submitted book chapters under review

1.Book title: Algae as a Natural Solution for Water-Food-Energy Nexus, Section 4: Microalgae and cyanobacteria for food applications, Chapter 4.6: Safety, toxicological and allergenic aspects of using algae for food. Authors: Christine Kyarimpa, Tom Omute, Caroline K. Nakiguli, Alice V. Khanakwa4, Christopher Angiro, Ivan Kahwa, Fortunate Ahumuza, Timothy Omara*. Publisher: Springer Nature Singapore Pte Ltd. 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore.

2.Book title: Nutraceuticals Inspiring the Contemporary Therapy for Lifestyle Diseases. Chapter: Nutraceutical applications of Seaweeds and their Phytocompounds in Nutrition and Treatment of Diseases. Authors: Ivan Kahwa, Timothy Omara , Innocent Ayesiga , Gael Noel Neh Neba Ambe , Zehbanaz Javidbhai Panwala , Rachel Mbabazi , Shabnoor Iqbal , Christine Kyarimpa , Christine Betty Nagawa , Kamal Shah ,Nagendra Singh Chauhan* Publisher: CRC Press

You can view my works on the following professional sites:

Research Gate: https://www.researchgate.net/profile/Ivan-Kahwa

Google Scholar: https://scholar.google.com/citations?user=tOwrvqoAAAAJ&hl=en

ORCID: https://orcid.org/0000-0002-6440-3437

Linkedin: https://de.linkedin.com/in/ivan-kahwa-865450159

Ivan Kahwa

View More north_east

This article answers, “Does Celexa cause dry skin?” We will also discuss the scientific evidence and tips to help with dry skin issues with Celexa.

Does Celexa cause dry skin?

Yes, Celexa can cause dry skin, though the incidence of this side effect is relatively low.

Celexa (Citalopram) is a selective serotonin reuptake inhibitor, primarily prescribed for managing depression, panic disorder, anxiety, and obsessive-compulsive disorder.

Celexa may occasionally result in skin-related side effects, such as dry skin, eczema, or rashes. (1)

Acknowledging that individual responses to these medications may exhibit variability is essential. What causes dry skin in one person may not have the same effect on another.

What does research suggest?

Research has provided valuable insights into the dermatological effects of Selective Serotonin Reuptake Inhibitors (SSRIs), including Celexa (Citalopram).

A comprehensive study has shown that SSRIs have the potential to induce skin dryness, irritation, and skin rash. It can even trigger allergic contact dermatitis in some individuals. This observation underscores the capability of SSRIs, such as Citalopram, to permeate the skin and cause skin inflammation and rash. (3)

Moreover, an in-depth literature review underscores that SSRIs, including Citalopram, can contribute to cutaneous adverse drug reactions. These reactions encompass manifestations like eczema, dry skin, skin rash, and hyperpigmentation. (4)

Another study highlights the role of recurrent exposure to SSRI, in causing skin sensitisation and allergic reactions, particularly skin rash, in specific individuals. (5)

This research emphasises the cumulative nature of this effect, indicating that prolonged exposure to Citalopram may heighten the risk of developing skin allergies and other dermatological health concerns.

These research findings collectively shed light on the potential impact of SSRIs, focusing on Citalopram (Celexa), on skin health, suggesting a spectrum of conceivable skin-related side effects.

Consulting with a healthcare professional is paramount when addressing concerns regarding these potential dermatological side effects associated with SSRIs, especially those about dry skin, skin rash, and Citalopram.

What to do if Celexa causes dry skin?

If you’re experiencing dry skin as a result of using Celexa, here are five practical steps to consider:

Consult your doctor: The first and foremost step is to reach out to your doctor. They can assess your situation and determine if adjustments to your dosage are necessary. Your doctor is your best guide in managing any medication-related side effects.

Stay hydrated: Keeping your body well-hydrated is crucial. Drink an ample amount of water daily to maintain skin moisture from within. Hydration plays a significant role in combating the effects of dry skin.

Avoid hot showers: When showering or bathing, steer clear of hot water, as it can deprive your skin of natural oils and aggravate dryness. Instead, use lukewarm water for a gentler approach.

Use a humidifier: Introducing a humidifier to your living space can help maintain the right moisture levels in the air. This, in turn, can contribute to healthier, more hydrated skin.

Choose a quality moisturiser: Invest in a good moisturiser designed for sensitive or dry skin. Apply it regularly to keep your skin well-nourished and protected.

You can manage and alleviate dry skin by following these steps while taking Celexa. However, it’s essential to coordinate your approach with your healthcare provider to ensure your overall well-being is maintained.

Other skin-related side effects of Celexa

Other than dry skin, Celexa can cause these skin issues: (1,2)

Rash
Itching (Pruritus)
Hives (Urticaria)
Acne
Skin Discoloration
Eczema
Hair Loss (Alopecia)
Dermatitis
Psoriasis

Certain side effects, such as rash and pruritus, are more frequently observed in individuals taking Celexa, while the remaining adverse effects are less prevalent.

Conclusion

In conclusion, the potential for Celexa to cause dry skin is a valid concern, although its occurrence is relatively low. While some individuals may experience this side effect, it’s important to remember that the impact of medication can vary from person to person.